Kiora Pharmaceuticals Inc

NASDAQ:KPRX  
2.78
0.00 (0.00%)
7:45:11 PM EDT: $2.76 -0.02 (-0.72%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)9.55M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.75 Million
Adjusted EPS-$0.66
See more estimates
10-Day MA$2.74
50-Day MA$2.83
200-Day MA$3.18
See more pivots

Kiora Pharmaceuticals Inc Stock, NASDAQ:KPRX

332 Encinitas Boulevard, Suite 102, Encinitas, California 92024
United States of America
Phone: +1.858.224.9600
Number of Employees: 12

Description

Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.